Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Kaitlin L. Musick
Advertisement
Articles by Kaitlin L. Musick
Advertisement
Latest Updated Articles
Combating Advancing Cancers With CAR T-Cell TherapyPublished: September 8th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
2
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
3
Understanding Cyclobenzaprine Hydrochloride: An Emerging Therapy for Fibromyalgia
4
FDA Approves Reformulated Ranitidine After 5-Year Absence
5
